[Fund information Portfolio (as at 31/08/16) Share price USD 17.03 NAV per share USD 18.68 Discount (-) / Premium Current -8.8! Shares in issue 6,447,637 Fund code Bloomberg JFC US ISIN US46614T1079 Sedol 2471392 Fund % 19.5% 16.3% 14.5% 13.2% 11.7% 10.7% 6.8% 0.0% 7.3% 100.0% Portfolio review China - ‘A’ Shares Hong Kong Taiwan China - Hong Kong ‘P] []
[CONTENTS 2 Additional Information 3 Corporate Information 4 Letter to Shareholders 6 Management’s Discussion and Analysis of Financial Condition and Results of Operations 16 Corporate Governance Report 26 Other Information 34 Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 35 Condensed Consolidated Statements of Financial Position 36 Condensed Consolidated Statements of Changes in Equity 37 Condensed Consolidated]
[CONTENTS 2 Additional Information 3 Corporate Information 4 Letter to Shareholders 6 Management’s Discussion and Analysis of Financial Condition and Results of Operations 16 Corporate Governance Report 26 Other Information 34 Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Income 35 Condensed Consolidated Statements of Financial Position 36 Condensed Consolidated Statements of Changes in Equity 37 Condensed Consolidated]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes Aluminum Corporation of China Limited Date September 22, 2016 By About the Company Our contact information of this release is: * Business address: No. 62 North Xizhimen Street, Haidian District, Beijing, People's Republic of China, 100082 * Telephone]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes Aluminum Corporation of China Limited Date September 22, 2016 By About the Company Our contact information of this release is: * Business address: No. 62 North Xizhimen Street, Haidian District, Beijing, People's Republic of China, 100082 * Telephone]
[Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd. Xianyang Yongsheng has three production lines, including health “Yuye” wine” (a popular brand in the PRC market), tea and capsules, and maintains a 24-acre Chinese herbal medicine ecological park. Mr. Wang Ronghua, the Chairman of Biostar, commented, “We have been following the developments of the] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): September 7, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ☐ ☐ ☐]
[Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd. Xianyang Yongsheng has three production lines, including health “Yuye” wine” (a popular brand in the PRC market), tea and capsules, and maintains a 24-acre Chinese herbal medicine ecological park. Mr. Wang Ronghua, the Chairman of Biostar, commented, “We have been following the developments of the] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): September 7, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ☐ ☐ ☐]
[Fund information Portfolio (as at 31/08/16) Share price USD 17.03 NAV per share USD 18.68 Discount (-) / Premium Current -8.8! Shares in issue 6,447,637 Fund code Bloomberg JFC US ISIN US46614T1079 Sedol 2471392 Fund % 19.5% 16.3% 14.5% 13.2% 11.7% 10.7% 6.8% 0.0% 7.3% 100.0% Portfolio review China - ‘A’ Shares Hong Kong Taiwan China - Hong Kong ‘P] []
